See the DrugPatentWatch profile for Gadoterate
What is gadoterate?
Gadoterate (also written as gadoterate meglumine) is a gadolinium-based contrast agent used in medical imaging, most often for MRI. It helps make certain tissues and abnormalities show up more clearly on scans.
What is it used for in MRI?
Clinicians use gadoterate to improve visualization of areas that may have abnormal blood flow, breakdown of the blood-brain barrier, inflammation, or tumors, depending on the scan type and body region.
How is gadoterate given?
Gadoterate is administered by injection into a vein shortly before or during the MRI exam.
Common side effects and what patients should watch for
Like other gadolinium contrast agents, gadoterate can cause side effects in some people, such as nausea, headache, or a temporary sensation at the injection site. More serious reactions are uncommon.
Patients should report any symptoms during or after the scan, especially:
- trouble breathing
- swelling of the face or throat
- hives or widespread rash
Who needs extra caution?
Extra caution is important for people with reduced kidney function, because impaired clearance of gadolinium can increase risk. The imaging team typically screens patients for kidney disease before giving gadoterate.
Gadoterate vs other gadolinium agents: what’s different?
Gadoterate is one specific “type” of gadolinium contrast agent (a particular chemical formulation). Other gadolinium agents differ in their stability and dosing/labeling details. The right agent depends on the imaging indication, local protocols, and patient factors like kidney function.
Do you need an FDA approval/patent/exclusivity answer?
If you mean a specific product brand name or want regulatory details (FDA approval, labeling, warnings, or availability by country), share the brand name and the country you’re asking about.